Breaking News Instant updates and real-time market news.

OPNT

Opiant Pharmaceuticals

$13.00

-0.24 (-1.81%)

04:55
07/19/19
07/19
04:55
07/19/19
04:55

Opiant Pharmaceuticals management to meet with Northland

Meetings to be held in Chicago, IL on July 18 in Minneapolis, MN on July 19 hosted by Northland.

  • 19

    Jul

OPNT Opiant Pharmaceuticals
$13.00

-0.24 (-1.81%)

09/28/18
CANT
09/28/18
NO CHANGE
Target $42
CANT
Overweight
Opiant Pharmaceuticals price target raised to $42 from $32 at Cantor Fitzgerald
Cantor Fitzgerald analyst Brandon Folkes raised his price target for Opiant Pharmaceuticals to $42 citing upwards earnings revisions for Narcan and a revised share count post the recently completed equity financing. The company is developing treatments focused on multiple addictions including a next-generation, improved Narcan, OPNT003, which has a longer half-life, offering better reversal outcomes in fentanyl-related overdoses, Folkes tells investors in a research note. He believes Emergent BioSolutions' recent acquisition of Adapt Pharma for $735M underscores the value of the opioid overdose market. As Opiant advances its pipeline, investors to begin to appreciate the market potential of its candidates, which should drive the stock higher, the analyst contends. Folkes reiterates an Overweight rating on the shares.
10/26/18
10/26/18
NO CHANGE

Opiant Pharma initiates patent challenge for Perrigo's generic version of Narcan
Opiant Pharmaceuticals (OPNT), Adapt Pharma Operations, Adapt Pharma Inc. and Adapt Pharma Ltd. initiated patent litigation on October 25 in the District Court for the District of New Jersey regarding Perrigo's (PRGO) Paragraph IV Abbreviated New Drug Application for naloxone hydrochloride nasal spray 4mg, asserting patents listed in the Orange Book for Narcan. This action formally initiates the litigation process. Narcan Nasal Spray is indicated for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. Annual market sales for the 12 months ending August 2018 were $95M..
03/22/19
CANT
03/22/19
NO CHANGE
Target $38
CANT
Overweight
Opiant pipeline remains free at current share levels, says Cantor Fitzgerald
Cantor Fitzgerald analyst Brandon Folkes reiterates an Overweight rating on Opiant Pharmaceuticals with a $38 price target following the company's Q4 results. The company is developing treatments focused on multiple addictions, including a potential longer-lasting product for opioid overdose, Folkes tells investors in a research note. He continues to believe Opiant "remains significantly undervalued at current levels." The company's ability to successfully develop products targeting addiction and overdose has been validated by the approval of Narcan nasal spray in 2015. Further, investors are getting the pipeline for free at current share levels, says the analyst.
05/29/19
NORL
05/29/19
INITIATION
Target $42
NORL
Outperform
Opiant Pharmaceuticals initiated with an Outperform at Northland
Northland analyst Carl Byrnes initiated Opiant Pharmaceuticals with an Outperform and $42 price target given its established track record developing NARCAN for opioid overdose. Byrnes believes Opiant's valuation "woefully" understates the company's extensive pipeline, NARCAN royalty stream, government-based funding of key programs, and cash.

TODAY'S FREE FLY STORIES

07:55
08/23/19
08/23
07:55
08/23/19
07:55
General news
Fed's Bullard remains worried about low inflation and downside risks to the economy »

Fed's Bullard…

AMRC

Ameresco

$14.62

-0.11 (-0.75%)

07:54
08/23/19
08/23
07:54
08/23/19
07:54
Conference/Events
Cowen alternative energy analyst to hold analyst/industry conference call »

Alternative Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

ATGE

Adtalem Global Education

$50.93

-0.37 (-0.72%)

07:54
08/23/19
08/23
07:54
08/23/19
07:54
Recommendations
Adtalem Global Education analyst commentary  »

Adtalem Global Education…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

CERN

Cerner

$71.62

-0.15 (-0.21%)

07:52
08/23/19
08/23
07:52
08/23/19
07:52
Downgrade
Cerner rating change  »

Cerner downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 09

    Sep

UIS

Unisys

$7.70

-0.04 (-0.52%)

07:52
08/23/19
08/23
07:52
08/23/19
07:52
Hot Stocks
Unisys awarded contract valued at up to $25M by state of Georgia »

Unisys announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

07:52
08/23/19
08/23
07:52
08/23/19
07:52
Conference/Events
BTIG healthcare analysts to hold an analyst/industry conference call »

Healthcare Analysts,…

LYFT

Lyft

$51.31

-2.83 (-5.23%)

07:51
08/23/19
08/23
07:51
08/23/19
07:51
Recommendations
Lyft analyst commentary  »

JPMorgan keeps Overweight…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

07:49
08/23/19
08/23
07:49
08/23/19
07:49
Conference/Events
CLSA Asian tech analysts to hold an analyst/industry conference call »

Asian Technology Analysts…

LNDC

Landec

$10.99

-0.07 (-0.63%)

07:48
08/23/19
08/23
07:48
08/23/19
07:48
Initiation
Landec initiated  »

Landec initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$148.15

0.11 (0.07%)

, PVTL

Pivotal Software

$13.69

0.01 (0.07%)

07:41
08/23/19
08/23
07:41
08/23/19
07:41
Recommendations
VMware, Pivotal Software, Carbon Black analyst commentary  »

VMware investors will…

VMW

VMware

$148.15

0.11 (0.07%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

WMT

Walmart

$111.90

-0.11 (-0.10%)

, TSLA

Tesla

$222.07

1.18 (0.53%)

07:39
08/23/19
08/23
07:39
08/23/19
07:39
Periodicals
Walmart, Tesla seek to resolve issues surrounding solar systems, Reuters reports »

Walmart (WMT) and Tesla…

WMT

Walmart

$111.90

-0.11 (-0.10%)

TSLA

Tesla

$222.07

1.18 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 15

    Sep

  • 23

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

AAPL

Apple

$212.55

-0.14 (-0.07%)

07:38
08/23/19
08/23
07:38
08/23/19
07:38
Periodicals
Apple contractors listened to 1,000 Siri recordings a day, Irish Examiner says »

Jess Casey of the Irish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$19.33

-0.72 (-3.59%)

07:36
08/23/19
08/23
07:36
08/23/19
07:36
Recommendations
L Brands analyst commentary  »

L Brands price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 21

    Nov

CRM

Salesforce

$148.26

0.86 (0.58%)

07:36
08/23/19
08/23
07:36
08/23/19
07:36
Recommendations
Salesforce analyst commentary  »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

BBBY

Bed Bath & Beyond

$8.75

0.77 (9.65%)

, MDR

McDermott

$4.39

0.24 (5.78%)

07:35
08/23/19
08/23
07:35
08/23/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

BBBY

Bed Bath & Beyond

$8.75

0.77 (9.65%)

MDR

McDermott

$4.39

0.24 (5.78%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

DKS

Dick's Sporting

$34.14

1.17 (3.55%)

07:34
08/23/19
08/23
07:34
08/23/19
07:34
Recommendations
Dick's Sporting analyst commentary  »

Dick's Sporting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

RTRX

Retrophin

$13.55

-3.84 (-22.08%)

07:29
08/23/19
08/23
07:29
08/23/19
07:29
Recommendations
Retrophin analyst commentary  »

Retrophin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$148.15

0.11 (0.07%)

, PVTL

Pivotal Software

$13.69

0.01 (0.07%)

07:28
08/23/19
08/23
07:28
08/23/19
07:28
Recommendations
VMware, Pivotal Software, Carbon Black analyst commentary  »

VMware price target…

VMW

VMware

$148.15

0.11 (0.07%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

CRM

Salesforce

$148.26

0.86 (0.58%)

07:28
08/23/19
08/23
07:28
08/23/19
07:28
Recommendations
Salesforce analyst commentary at Canaccord »

Salesforce price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 12

    Dec

  • 16

    Dec

07:27
08/23/19
08/23
07:27
08/23/19
07:27
Conference/Events
Federal Reserve Chairman Jerome Powell speaks at symposium »

Federal Reserve Chairman…

07:24
08/23/19
08/23
07:24
08/23/19
07:24
Conference/Events
Federal Reserve Bank of St. Louis president to be interviewed »

James Bullard, President…

INTU

Intuit

$276.05

-0.29 (-0.10%)

07:24
08/23/19
08/23
07:24
08/23/19
07:24
Recommendations
Intuit analyst commentary  »

Intuit price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

TGI

Triumph Group

$22.70

0.19 (0.84%)

07:22
08/23/19
08/23
07:22
08/23/19
07:22
Downgrade
Triumph Group rating change  »

Triumph Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VMW

VMware

$148.15

0.11 (0.07%)

, PVTL

Pivotal Software

$13.69

0.01 (0.07%)

07:22
08/23/19
08/23
07:22
08/23/19
07:22
Recommendations
VMware, Pivotal Software, Carbon Black analyst commentary  »

VMware price target…

VMW

VMware

$148.15

0.11 (0.07%)

PVTL

Pivotal Software

$13.69

0.01 (0.07%)

CBLK

Carbon Black

$24.52

1.77 (7.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 10

    Oct

WAL

Western Alliance

$43.59

0.025 (0.06%)

07:18
08/23/19
08/23
07:18
08/23/19
07:18
Recommendations
Western Alliance analyst commentary  »

Western Alliance added to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.